REMdesivir-HU Clinical Study and Severe Covid-19 Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- SARS CoV-2 Infection
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: open-label, multi-center, interventional safety studyMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 12 years and 100 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04610541
- Collaborators
- HECRIN Consortium
- Hungarian Ministry of Innovation and Technology
- Investigators
- Not Provided
Get Well Soon